Alembic Pharmaceuticals informs about press release

26 Nov 2019 Evaluate

With reference to 'Alembic Pharmaceuticals receives USFDA Final Approval for Silodosin Capsules, 4 mg and 8 mg', Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Silodosin Capsules, 4 mg and 8 mg. the company has submitted its press release. 

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×